Based on the observation of the increased expression of BRD4 in the coronary vasculature of the remodeled RV in PAH patients and MCT rats [105], inhibition of BRD4 by apabetalone (RVX-208) in PAB rats was found to improve adaptation to pressure overload. Here, BRD4 is linked to pulmonary arterial hypertension.